Esios, Matt Glazer M.
HRN: 19-23-56 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/07/2022
06/13/2022
IV
285mg
Q6hrs
Pcap B; AGE With Mod DHn
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes